Nayan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.91 M
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 M
- Satisfied Charges ₹ 0.90 M
About Nayan Pharmaceuticals
Nayan Pharmaceuticals Limited (NPL) is a Public Limited Indian Non-Government Company incorporated in India on 26 November 1996 and has a history of 28 years and two months. Its registered office is in Patiala, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹2.30 M. The company has closed loans amounting to ₹0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Shiv Srivastava, Akshay Srivastava, and Manohar Verma serve as directors at the Company.
Company Details
-
Location
Patiala, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231PB1996PLC019085
-
Company No.
019085
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Nayan Pharmaceuticals Limited offer?
Nayan Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Arthritic Drugs, Cough Syrup, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Nayan Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Srivastava
|
Director | 26-Nov-1996 | Current |
|
Akshay Srivastava
|
Director | 16-Jul-2016 | Current |
|
Manohar Verma
|
Director | 14-Dec-2022 | Current |
Financial Performance of Nayan Pharmaceuticals.
Nayan Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nayan Pharmaceuticals?
In 2017, Nayan Pharmaceuticals had a promoter holding of 96.70% and a public holding of 3.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.30 M
₹0.90 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Canara Bank | ₹1.60 M | Open |
| 07 Jan 1998 | Canara Bank | ₹0.70 M | Open |
| 13 Aug 2009 | Canara Bank | ₹0.50 M | Satisfied |
| 07 Jan 1998 | Canara Bank | ₹0.40 M | Satisfied |
How Many Employees Work at Nayan Pharmaceuticals?
Unlock and access historical data on people associated with Nayan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nayan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nayan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
